Irisin: good or bad for the bone? A new path forward after the reported discovery of irisin receptor?
- 25 January 2019
- journal article
- editorial
- Published by Elsevier BV in Metabolism
- Vol. 93, 100-102
- https://doi.org/10.1016/j.metabol.2019.01.013
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Circulating Sclerostin and Irisin Are Related and Interact with Gender to Influence Adiposity in Adults with PrediabetesInternational Journal of Endocrinology, 2014
- Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 monthsOsteoporosis International, 2014
- Irisin Enhances Osteoblast DifferentiationIn VitroInternational Journal of Endocrinology, 2014
- Evidence against a Beneficial Effect of Irisin in HumansPLOS ONE, 2013
- Irisin: A renaissance in metabolism?Metabolism, 2013
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesisNature, 2012
- Matrix-embedded cells control osteoclast formationNature Medicine, 2011
- The amazing osteocyteJournal of Bone and Mineral Research, 2010
- Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/SclerostinJournal of Biological Chemistry, 2008
- The integrinsGenome Biology, 2007